SGMO - Sangamo Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate-0.34-0.35-1.36-1.34
Low Estimate-0.4-0.45-1.52-1.75
High Estimate-0.28-0.26-1.20.05
Year Ago EPS-0.13-0.18-0.7-1.36
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7788
Avg. Estimate12.16M14.56M53.47M83.47M
Low Estimate7M7M39.6M39.6M
High Estimate18.1M22.35M62.3M241.2M
Year Ago SalesN/A26.84M84.45M53.47M
Sales Growth (year/est)N/A-45.70%-36.70%56.10%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.15-0.21-0.25-0.36
EPS Actual-0.13-0.18-0.41-0.26
Difference0.020.03-0.160.1
Surprise %13.30%14.30%-64.00%27.80%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.34-0.35-1.36-1.34
7 Days Ago-0.34-0.35-1.36-1.34
30 Days Ago-0.34-0.35-1.36-1.31
60 Days Ago-0.34-0.36-1.37-1.3
90 Days Ago-0.36-0.38-1.5-1.31
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSGMOIndustrySectorS&P 500
Current Qtr.-161.50%N/AN/A-0.02
Next Qtr.-94.40%N/AN/A0.07
Current Year-94.30%N/AN/A-0.02
Next Year1.50%N/AN/A0.14
Next 5 Years (per annum)-17.90%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A